Break free from Quality Roadblocks
Join our experts from Lachman, Regenxbio, PPD and Etena Therapeutics as they discuss key consideration of successful CGT manufacturing and quality strategies.
Key discussions will include:
- Developing a successful regulatory strategy in the evolving CGT field
- Achieving CGT quality and compliance through effective quality systems implementation
- Navigating increasing CGT manufacturing demand and capacity and scalability challenge
- Avoiding quality and compliance issues to ensure patient access
Meet the speakers

Sarah Thomas
Senior Vice President of Quality, REGENXBIO

Keith A. Lamb, Ph.D.
Executive Director, Lachman Consultant Services, Inc.

Susan McClatchey
Vice President, Quality, Eterna Therapeutics

Richard Dennett
Senior Director CMC & Regulatory Strategy, PPD | Thermo Fisher Scientific

Shardha Millington
Consultant, Citeline Moderator
Gain insight into successful strategies in overcoming obstacles in CGT manufacturing and quality
Register now to secure your spot!
By completing this form you agree Lachman Consultant Services, Inc. and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy and Pharma Intelligence UK Ltd’s privacy policy.